© 2021 BioMarin. All rights reserved.

BioMarin to Participate in Two Upcoming Virtual Investor Conferences
- 2020 Wedbush PacGrow Healthcare Virtual Conference on August 11
- Canaccord Genuity 40th Annual Growth Conference on August 13
Aug 10, 2020

SAN RAFAEL, Calif., Aug. 10, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jeff Ajer, Executive Vice President and Chief Commercial Officer, and Brian Mueller, Executive Vice President, Chief Financial Officer will participate in the 2020 Wedbush PacGrow Healthcare Virtual Conference on August 11, 2020 at 10:55am ET and Henry Fuchs, M.D., President, Worldwide Research & Development and Brian Mueller, Executive Vice President, Chief Financial Officer, will participate in the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020 at 1:00pm ET.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:


Investors

Media

Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451

 

SOURCE BioMarin Pharmaceutical Inc.